AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
133.49B
HNCAX
Price
$20.33
Change
+$0.15 (+0.74%)
Updated
Sep 5 closing price
Net Assets
342.14M
Interact to see
Advertisement

AEPCX vs HNCAX

Header iconAEPCX vs HNCAX Comparison
Open Charts AEPCX vs HNCAXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets133.49B
Hartford International Growth A
Price$20.33
Change+$0.15 (+0.74%)
VolumeN/A
Net Assets342.14M
AEPCX vs HNCAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. HNCAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and HNCAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. HNCAX (342M). AEPCX pays higher dividends than HNCAX: AEPCX (0.16) vs HNCAX (0.05). AEPCX was incepted earlier than HNCAX: AEPCX (25 years) vs HNCAX (24 years). AEPCX (1.57) is less costly to investors than HNCAX (1.33). AEPCX is a more actively managed with annual turnover of: 35.00 vs. HNCAX (31.00). AEPCX has a lower initial minimum investment than HNCAX: AEPCX (250) vs HNCAX (2000). HNCAX annual gain was more profitable for investors over the last year : 19.58 vs. AEPCX (7.59). HNCAX return over 5 years is better than : 27.39 vs. AEPCX (7.78).
AEPCXHNCAXAEPCX / HNCAX
Total Expense Ratio1.571.30121%
Annual Report Gross Expense Ratio1.571.33118%
Fund Existence25 years24 years-
Gain YTD15.03819.37878%
Front LoadN/A6%-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets133B342M38,889%
Annual Yield % from dividends0.160.05357%
Returns for 1 year7.5919.5839%
Returns for 3 years32.6563.7851%
Returns for 5 years7.7827.3928%
Returns for 10 years34.3477.0045%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.270.03
+2.42%
Pacific Biosciences of California
VVX56.681.23
+2.22%
V2X
GANX1.760.02
+1.15%
Gain Therapeutics
LINE40.590.13
+0.32%
Lineage Inc.
QVCGP6.980.02
+0.29%
QVC Group Inc.